Literature DB >> 11985996

Laparoscopic fundoplication for symptomatic but physiologic gastroesophageal reflux.

R C Bell1, P Hanna, S Brubaker.   

Abstract

Esophageal pH monitoring identifies some patients who have physiologic amounts of esophageal acid exposure but have a strong correlation between symptoms of esophageal reflux events. These patients with symptomatic physiologic reflux probably have enhanced sensory perception of reflux events and may be difficult to control with acid-suppressive therapy. Little is known about the role of fundoplication in such patients. Patients with no endoscopic evidence of gastroesophageal reflux disease and a normal 24-hour pH composite score (<22.4 in our laboratory), but a symptom index (SI = number of symptoms with pH <4/total number of symptoms) greater than 50% were offered laparoscopic fundoplication if acid-suppressive therapy was unsatisfactory. This group comprised 18 (4%) of 459 patients undergoing fundoplication at our institution. Heartburn, dysphagia, and reflux symptoms were scored on a scale of 0 to 10 with patients on and off medicine preoperatively, and at a mean of 7.2 months (range 1 to 32 months) postoperatively. The 18 patients with symptomatic physiologic reflux (6 males and 12 females) had heartburn as a major complaint. Preoperative response to proton pump inhibitors for heartburn was 72% and for all symptoms was 60%. The group had a mean pH composite score of 14 (range 4 to 22). The symptom used to calculate the symptom index was heartburn in 12 patients, regurgitation in three, chest pain in two, and cough in one. An average of 18 symptoms (range 2 to 56) were recorded. The mean symptom index was 82% (range 50% to 100%). A Nissen fundoplication was performed in nine patients and a Toupet fundoplication in nine. Surgery was successful (>90%) in alleviating reflux symptoms in 14 patients and partially successful (>75%) in three of the remaining four patients. Gas bloat and dysphagia were seen in one patient each. Fundoplication is effective at relieving reflux symptoms in carefully selected patients with symptomatic physiologic reflux, with minimal side effects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11985996     DOI: 10.1016/s1091-255x(01)80083-4

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  17 in total

1.  Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication.

Authors:  G M Campos; J H Peters; T R DeMeester; S Oberg; P F Crookes; S Tan; S R DeMeester; J A Hagen; C G Bremner
Journal:  J Gastrointest Surg       Date:  1999 May-Jun       Impact factor: 3.452

2.  Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux--the "sensitive oesophagus".

Authors:  R G Watson; T C Tham; B T Johnston; N I McDougall
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

Review 3.  Is functional dyspepsia largely explained by gastro-oesophageal reflux disease?

Authors:  J Wayman; S M Griffin; F C Campbell
Journal:  Baillieres Clin Gastroenterol       Date:  1998-09

4.  Ambulatory 24-hour esophageal pH monitoring. Technology searching for a clinical application.

Authors:  B W Ward; W C Wu; J E Richter; K W Lui; D O Castell
Journal:  J Clin Gastroenterol       Date:  1986       Impact factor: 3.062

5.  Reflux related symptoms in patients with normal oesophageal exposure to acid.

Authors:  G Shi; S Bruley des Varannes; C Scarpignato; M Le Rhun; J P Galmiche
Journal:  Gut       Date:  1995-10       Impact factor: 23.059

6.  Clinical characteristics and natural history of symptomatic but not excess gastroesophageal reflux.

Authors:  K C Trimble; S Douglas; A Pryde; R C Heading
Journal:  Dig Dis Sci       Date:  1995-05       Impact factor: 3.199

7.  Mechanisms underlying the antireflux action of fundoplication.

Authors:  A C Ireland; R H Holloway; J Toouli; J Dent
Journal:  Gut       Date:  1993-03       Impact factor: 23.059

8.  Clinical and manometric results of laparoscopic partial (Toupet) and complete (Rosetti-Nissen) fundoplication.

Authors:  R C Bell; P Hanna; B Powers; J Sabel; D Hruza
Journal:  Surg Endosc       Date:  1996-07       Impact factor: 4.584

9.  Symptom index as a marker of gastro-oesophageal reflux disease.

Authors:  B T Johnston; R J McFarland; J S Collins; A H Love
Journal:  Br J Surg       Date:  1992-10       Impact factor: 6.939

10.  Importance of reflux symptoms in functional dyspepsia.

Authors:  P K Small; M A Loudon; B Waldron; D Smith; F C Campbell
Journal:  Gut       Date:  1995-02       Impact factor: 23.059

View more
  5 in total

1.  Current Diagnosis and Management of Suspected Reflux Symptoms Refractory to Proton Pump Inhibitor Therapy.

Authors:  Joel E Richter
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-09

2.  A Novel, Dynamic Statistical Model for Predicting Patient Satisfaction with Fundoplication Based on Pre-Operative Symptom Patterns.

Authors:  B L Woodham; R Meng; R H Roberts
Journal:  World J Surg       Date:  2017-11       Impact factor: 3.352

3.  New Approaches to Management of PPI-Refractory Gastroesophageal Reflux Disease.

Authors:  Fehmi Ates; Michael F Vaezi
Journal:  Curr Treat Options Gastroenterol       Date:  2014-03

4.  Therapeutic effects of laparoscopic fundoplication for nonerosive gastroesophageal reflux disease.

Authors:  Nobuo Omura; Hideyuki Kashiwagi; Fumiaki Yano; Kazuto Tsuboi; Yoshio Ishibashi; Naruo Kawasaki; Yutaka Suzuki; Katsuhiko Yanaga
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

5.  Esophageal Clearance in Laryngopharyngeal Reflux Disease: Correlation of Reflux Scintigraphy and 24-hour Impedance/pH in a Cohort of Refractory Symptomatic Patients

Authors:  Leticia Burton; Gregory L. Falk; Karl Baumgart; John Beattie; Scott Simpson; Hans Van der Wall
Journal:  Mol Imaging Radionucl Ther       Date:  2020-02-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.